Grenada vs North Macedonia: Hepatitis B surface antigen (HBsAg) prevalence
Grenada
0.2%
in 2024
North Macedonia
0.2%
in 2024
Grenada rank
82nd
North Macedonia rank
82nd
Hepatitis B surface antigen (HBsAg) prevalence over time
- Grenada
- North Macedonia
How they compare
Grenada currently reports 0.2% against 0.2% in North Macedonia, a difference of 0.0%.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Grenada ahead.
Grenada ranks 82nd and North Macedonia ranks 82nd of 194 countries.
Grenada has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Grenada | North Macedonia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.3% | 0.1% | 0.2% | Grenada |
| 2020s | 0.2% | 0.1% | 0.1% | Grenada |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Grenada or North Macedonia?
- Grenada, at 0.2% against 0.2% in North Macedonia as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Grenada and North Macedonia?
- 0.0%, with Grenada ahead.
- How many years of comparable data are there for Grenada and North Macedonia?
- 10 years are reported by both, from 2015 to 2024.
- How do Grenada and North Macedonia rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Grenada ranks 82nd and North Macedonia ranks 82nd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.